GHB

DRUG3 trials

Sponsors

Erich Seifritz, Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia, Assistance Publique - Hôpitaux de Paris

Conditions

Critical CareHIVMajor Depressive DisorderPharmacokinetic InteractionsSleep Disorder (Disorder)

Phase 1

Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat

CompletedNCT04322214

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaHIV, Pharmacokinetic Interactions

Start: 2020-01-30End: 2020-04-30Updated: 2020-07-22

Phase 2

Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

CompletedNCT04082806

Erich SeifritzMajor Depressive Disorder

Start: 2020-08-06End: 2022-04-06Updated: 2022-05-12

Electrophysiological Analysis of Gamma-Hydroxybutyrate-induced Sleep in Intensive Care Patients

Not yet recruitingNCT07596342

Assistance Publique - Hôpitaux de ParisCritical Care, Sleep Disorder (Disorder)

Start: 2026-06-01End: 2027-10-01Target: 24Updated: 2026-05-22

Related Papers

REPURPOSING OF GAMMA-HYDROXYBUTYRATE IN DEPRESSION: A RANDOMIZED PLACEBO-CONTROLLED PROOF-OF-CONCEPT CLINICAL TRIAL

The International Journal of Neuropsychopharmacology2025-02-01

Absence of drug–drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat

Journal of Antimicrobial Chemotherapy2021-09-096 citations